C-Fos activation in the periaqueductal gray following acute morphine-3β-d-glucuronide or morphine administration

Physiology and Behavior

Volumn 130, Issue , 2014, Pages 28-33

  Arout, Caroline A ^a   Caldwell, Megan ^b   McCloskey, Daniel P ^a,b   Kest, Benjamin ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

C Fos; Hyperalgesia; Morphine; Morphine 3 d glucuronide; Periaqueductal gray

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; NALTREXONE; PROTEIN C FOS; SODIUM CHLORIDE; CENTRAL STIMULANT AGENT; MORPHINE DERIVATIVE; MORPHINE-3-GLUCURONIDE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; CELL DENSITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HYPERALGESIA; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATENT PERIOD; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; INBRED MOUSE STRAIN; METABOLISM; NERVE CELL; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MICE, INBRED STRAINS; MICROSCOPY, CONFOCAL; MORPHINE; MORPHINE DERIVATIVES; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEURONS; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY; PROTO-ONCOGENE PROTEINS C-FOS; RANDOM ALLOCATION;

EID: 84897413716     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.02.056     Document Type: Article

References (47)

1. Angst M.S., Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104(3):570-587.
2. Antonilli L., Petecchia E., Caprioli D., Badiani A., Nencini P. Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat. Psychopharmacology (Berl) 2005, 182:58-64.
3. A receptor complex. Life Sci 1994, 54:687-694.
4. Bennett G.J., Mayer D.J. Inhibition of spinal cord interneurons by narcotic microinjection and focal electrical stimulation in the periqueductal central gray matter. Brain Res 1979, 172:243-257.
5. Bilsky E.J., Inturrisi C.E., Sadée W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain 1996, 68(2-3):229-237.
6. Chieng B.C.H., Hallberg C., Nyberg F.J., Christie M.J. Enhanced c-Fos in periaqueductal grey GABAergic neurons during opioid withdrawal. Somatosens Syst Pain 2005, 16:1279-1283.
7. Christup L.L. Morphine metabolites. Acta Anaesthesiol Scand 1997, 41:116-122.
8. Crain S.M., Shen K.F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res 2001, 888:75-82.
9. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941, 72:74-79.
10. De Gregori S., De Gregori M., Ranzani G.N., Allegri M., Minella C., Regazzi M. Morphine metabolism, transport, and brain disposition. Metab Brain Dis 2012, 27:1-5.
11. Due M.R., Piekarz A.D., Wilson N., Feldman P., Ripsch M.S., et al. Neuroexcitatory effects of morphine-3-glucuronide are dependent on toll-like receptor 4 signaling. J Inflamm 2012, 9(200).
12. Ekblom M., Gardmark M., Hammerlund-Udenaes M. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine. Biopharm Drug Dispos 1993, 14:1-11.
13. 2 in the midbrain periaqueductal gray produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla. Pain 2004, 110:419-426.
14. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.X., et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun 2010, 24(1):83-95.
15. Jiang K.W., Xia Z.Z., Shui Q.X. Time-course of μ-calpain activation, c-Fos, c-Jun, HSP70 and HSP27 expression in neonatal hypoxic-ischemic rat brain. World J Pediatr 2005, 1:60-65.
16. Juni A., Klein G., Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res 2006, 1070:35-44.
17. Juni A., Klein G., Pintar J.E., Kest B. Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 2007, 147:439-444.
18. Juni A., Klein G., Kowalczyk B., Ragnauth A., Kest B. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment. Neuropharmacology 2008, 54:1264-1270.
19. Juni A., Cai M., Stankova M., Waxman A.R., Arout C., Klein G., et al. Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor. Anesthesiology 2010, 112:181-188.
20. Kaczmarek L. Handbook of chemical neuroanatomy. Immediate early genes and inducile transcription factors in mapping of the central nervous system function and dysfunction 2002, Vol. 19. (Retrieved from http://www.neuroinf.pl/Members/neurofizjo/Article.2006-01-03.4428/getFile).
21. Labella F.S., Pinsky C., Havlicek V. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res 1979, 174:263-271.
22. Lewis V.A., Gebhart G.F. Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res 1977, 124:283-303.
23. Lewis V.A., Gebhart G.F. Morphine-induced and stimulation-produced analgesias at coincident periaqueductal central gray loci: evaluation of analgesic congruence, tolerance, and cross-tolerance. Exp Neurol 1977, 57:934-955.
24. Lewis S.S., Hutchinson M.R., Rezvani N., Loram L.C., Zhang Y., Maier S.F., et al. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β. Neuroscience 2010, 165:569-583.
25. Loyd D.R., Morgan M.M., Murphy A.Z. Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat: a potential mechanism for sex differences in antinociception. Neuroscience 2007, 147(2):456-468.
26. McGaraughty S., Chu K.L., Bitner R.S., Martino B., El Kouhen R., Han P., et al. Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM. J Neurophysiol 2003, 90(4):2702-2710.
27. Nagar S., Raffa R.B. Looking beyond the administered drug: metabolites of opioid analgesics. Suppl Clin Pract 2008, 57:S1-S7.
28. Drug abuse in the decade of the brain 1997, IOS Press, Inc., Burke, VA. G.G. Nahas, T.F. Burks (Eds.).
29. Nemmani K.V., Mogil J.S. Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia. Neuropharmacology 2003, 44(3):304-310.
30. Nemmani K.V., Grisel J.E., Stowe J.R., Smith-Carliss R., Mogil J.S. Modulation of morphine analgesia by site-specific N-methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 2004, 109:274-283.
31. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan T.P., Hruby V.J., et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004, 61(1):126-148.
32. Ossipov M.H., Lai J., King T., Vanderah T.W., Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005, 80:319-324.
33. Pertovaara A., Wei H., H'm'l'inen M.M. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett 1996, 218:127-130.
34. Porreca F., Mosberg H.I., Hurst R., Hruby V.J., Burks T.F. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 1984, 230(2):341-348.
35. Quirion R., Zajac J.M., Morgat J.L., Roques B.P. Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands. Life Sci 1983, 33(Suppl. 1):227-230.
36. Quirion R. Pain, nociception and spinal opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 1984, 8(4-6):571-579.
37. Schurr A., Rigor B.M., Ho B.T., Dafny N. Periaqueductal gray neurons response to microiontophoretically injected morphine in naïve and morphine-dependent rats. Brain Res Bull 1981, 6(4-6):473-478.
38. Swartjes M., Mooren R.A.G., Waxman A.R., Arout C., Wetering K.V.D., Hartigh J.D., et al. Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide. Mol Med 2012, 18:1320-1326.
39. Tortorici V., Morgan M.M., Vanegas H. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats. Pain 2001, 89(2-3):237-244.
40. Van Dorp E.L.A., Kest B., Kowalczyk W.J., Morariu A.M., Waxman A.R., Arout C.A., et al. Morphine-6-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans. Anesthesiology 2009, 110:1356-1363.
41. VanElzakker M., Fevurly R.D., Breindel T., Spencer R.L. Environmental novelty is associated with a selective increase in fos expression in the output elements of the hippocampal formation and the perirhinal cortex. Learn Mem 2008, 15:899-908.
42. Van Straaten F., Müller R., Curran T., Van Beveren C., Verma I.M. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc Natl Acad Sci 1983, 80:3183-3187.
43. Vaughan C.W., Connor M. In search of a role for morphine metabolite morphine-3-glucuronide. Anesth Analg 2003, 97:311-312. 10.1213/01.ANE.0000078220.83604.7E.
44. Wahlström A., Hammar L., Lundin L.G., Rane A. Morphine metabolism in mouse brain. NIDA Res Monogr 1986, 75:603-606.
45. Waxman A.R., Juni A., Kowalczyk W., Arout C., Sternberg W.F., Kest B. Progesterone rapidly recruits female-typical opioid-induced hyperalgesic mechanisms. Physiol Behav 2010, 161:759-763. 10.1016/j.physbeh.2010.08.018.
46. Woolf C.J. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res 1981, 209:491-495. 10.1016/0006-8993(81)90176-1.
47. Yoburn B.C., Cohen A.H., Inturrisi C.E. Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. Pharmacol Exp Ther 1986, 237:126-130.